{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:50:28Z","timestamp":1779310228221,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gynecol Surg"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Increased awareness of leiomyosarcoma (LMS) risk during myomectomy or hysterectomy is essential. Objective and correct reasoning should prevail on any decision regarding the extent and type of surgery to employ. The anticipated risk of a sarcoma after myoma or uterus morcellation is low, and the frequency of leiomyosarcoma especially in women below the age of 40 is very rare. The prevalence data has a wide range and is therefore not reliable. The European Society of Gynaecological Endoscopy (ESGE) initiated a survey among its members looking into the frequency of morcellated leiomyosarcoma after endoscopic surgery.<\/jats:p>\n                <jats:p>The ESGE Central office sent 3422 members a structured electronic questionnaire with multiple answer choices for each question. After 3\u00a0months, the answers were classified with a unique number in the EXCEL spread sheet. Statistical analysis was done using the SPSS v.18.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 3422 members, 294 (8.6%) gynaecologists replied to the questionnaire; however, only 240 perform myomectomies by laparoscopy and hysteroscopy and hysterectomies by laparoscopy. The reported experience in performing laparoscopic myomectomy, hysteroscopic myomectomy, laparoscopic hysterectomy (LH), and laparoscopic subtotal hysterectomy (LSH) on an average was 10.8 (1\u201332) years. The vast majority of 67.1% had over 5\u00a0years of practice in laparoscopic surgery. The total number of 221 leiomyosarcoma was reported among 429,777 minimally invasive surgeries (laparoscopic and hysteroscopic myomectomies and LH and LSH), performed by all doctors in their lifetime. The overall reported sarcoma risk of all types of endoscopic myoma surgeries has been estimated to be 1.5% of operations which is very rare. Categorizing by type, 57 (0.06%) LMS were operated by laparoscopic myomectomy and 54 (0.07%) by hysteroscopic myomectomy, while 38 (0.13%) leiomyosarcoma operated by laparoscopic subtotal hysterectomy and 72 (0.31%) by laparoscopic hysterectomy. The probability of a sarcoma after morcellation to be falsely diagnosed by histopathology as a benign tumour and later identified as a sarcoma in a later examination has been reported and calculated to be 0.2%. The low risk of a sarcoma is also reflected by the small number of surgeries, where only 32 doctors reported that they operated once, 29 twice, and 18 operated on 3\u201310 sarcomas by laparoscopy during their lifetime.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The survey demonstrated that myomectomy by hysteroscopy or laparoscopy has similar risks of sarcoma with an estimated incidence of 0.07%, much lower than that by laparoscopic hysterectomy and subtotal hysterectomy. Hence, for young patients with myoma infertility problem and low risk for LMS, myomectomy by MIS can be the first option of treatment. The fact that only 12.5% (216\/1728) of uterine sarcoma cases are operated laparoscopically demonstrates the surgeons\u2019 awareness and alertness about LMS and the potential of spreading sarcomatous cells after myoma\/uterus power morcellation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10397-017-1027-z","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T11:52:14Z","timestamp":1512388334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Survey among ESGE members on leiomyosarcoma morcellation incidence"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4695-4630","authenticated-orcid":false,"given":"Vasilios","family":"Tanos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Br\u00f6lmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi Leon","family":"DeWilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"O\u2019Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elina","family":"Symeonidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"1027_CR1","first-page":"4","volume":"17","author":"FDA","year":"2014","unstructured":"FDA (2014) FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroids. Food Drug Adm 17:4 Ref Type: Internet Communication","journal-title":"Food Drug Adm"},{"issue":"4","key":"1027_CR2","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1016\/S1470-2045(14)70075-0","volume":"15","author":"BA Goff","year":"2014","unstructured":"Goff BA (2014) SGO not soft on morcellation: risks and benefits must be weighed. Lancet Oncol 15(4):e148\u2013e2045","journal-title":"Lancet Oncol"},{"key":"1027_CR3","doi-asserted-by":"crossref","unstructured":"Patient safety must be a priority in all aspects of care (2014)  Lancet Oncol. 15(2):123\u20132045","DOI":"10.1016\/S1470-2045(14)70042-7"},{"key":"1027_CR4","first-page":"215","volume":"127","author":"WGE","year":"2014","unstructured":"WGE (2014) Morcelleren: reactie vanWerkgroep Gynaecologische Endoscopie op FDA-advies; FDA ontraadt gebruik vanmorcellator. Ned Tijdschr Obstet Gynaecol 127:215","journal-title":"Ned Tijdschr Obstet Gynaecol"},{"issue":"3","key":"1027_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jmig.2014.03.005","volume":"21","author":"J Knight","year":"2014","unstructured":"Knight J, Falcone T (2014) Tissue extraction by morcellation: a clinical dilemma. J Minim Invasive Gynecol 21(3):319\u2013320","journal-title":"J Minim Invasive Gynecol"},{"issue":"19","key":"1027_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jama.2014.1093","volume":"311","author":"KA Kho","year":"2014","unstructured":"Kho KA, Nezhat CH (2014) Evaluating the risks of electric uterine morcellation. JAMA 311(19):905\u2013906","journal-title":"JAMA"},{"issue":"1","key":"1027_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ygyno.2011.08.035","volume":"124","author":"F Leung","year":"2012","unstructured":"Leung F, Terzibachian JJ (2012) Re: \u201cThe impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma\u201d. Gynecol Oncol 124(1):172\u2013173","journal-title":"Gynecol Oncol"},{"key":"1027_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10397-015-0878-4","volume":"12","author":"H Br\u00f6lmann","year":"2015","unstructured":"Br\u00f6lmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, Sawalhe S, van den Haak L, Jansen FW, Pijenenborg J, Taran FA, Brucker S, Waiez A, Campo R, O\u2019Donovan P, DeWilde RL (2015) Options on fibroid morcellation: a literature review. J Gynecol Surg 12:3\u201315","journal-title":"J Gynecol Surg"},{"issue":"2","key":"1027_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/01.grf.0000159538.27221.8c","volume":"48","author":"GL Ryan","year":"2005","unstructured":"Ryan GL, Syrop CH, Van Voorhis BJ (2005) Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol 48(2):312\u2013324","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"1027_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","volume":"104","author":"EE Wallach","year":"2004","unstructured":"Wallach EE, Vlahos NF (2004) Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 104(2):393\u2013406","journal-title":"Obstet Gynecol"},{"issue":"3","key":"1027_CR11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/bjc.2013.2","volume":"108","author":"AS Felix","year":"2013","unstructured":"Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, Wise LA, Anderson KE, Bernstein L et al (2013) The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer 108(3):727\u2013734","journal-title":"Br J Cancer"},{"issue":"1","key":"1027_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jmig.2014.08.781","volume":"22","author":"E Pritts","year":"2014","unstructured":"Pritts E, Parker WH, Brow J, Olive DL (2014) Outcome of occult uterine leiomyosarcoma after surgery for presumed uterine fibroids: a systematic review. J Min Invasive Gynecol 22(1):26\u201333","journal-title":"J Min Invasive Gynecol"},{"key":"1027_CR13","volume-title":"World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs","year":"2003","unstructured":"Tavassoli FA, Devilee P (eds) (2003) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs, 3rd edn. IARC Press, Lyon","edition":"3"},{"key":"1027_CR14","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","volume":"10","author":"F Amant","year":"2009","unstructured":"Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote (2009) Clinical management of uterine sarcomas. Lancet Oncol 10:1188","journal-title":"Lancet Oncol"},{"key":"1027_CR15","doi-asserted-by":"crossref","unstructured":"Pritts EA, Vanness DJ, Berek JS, Parker W, Feinberg R, Feinberg J, Olive DL (2015) The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gyn Surg 12(3):165\u201377","DOI":"10.1007\/s10397-015-0894-4"},{"key":"1027_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10397-014-0876-y","volume":"12","author":"V Tanos","year":"2015","unstructured":"Tanos V, Br\u00f6lmann H, DeWilde RL, O\u2019Donovan P, Campo R (2015) Myoma morcellation and leiomyosarcoma panic. Gynecol Surg 12:17\u201319","journal-title":"Gynecol Surg"},{"key":"1027_CR17","first-page":"322","volume":"127","author":"H Brolmann","year":"2014","unstructured":"Brolmann H, Hehenkamp WJK, Huirne JAF (2014) Heeft het myoom zijn onschuld verloren? Ned Tijdschr Obstet Gynaecol 127:322\u2013325","journal-title":"Ned Tijdschr Obstet Gynaecol"},{"issue":"2","key":"1027_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ygyno.2013.11.024","volume":"132","author":"T Oduyebo","year":"2014","unstructured":"Oduyebo T, Rauh-Hain AJ, Meserve EE, Seidman MA, Hinchcliff E, George S et al (2014) The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecol Oncol 132(2):360\u2013365","journal-title":"Gynecol Oncol"},{"key":"1027_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/0002-9378(90)91298-Q","volume":"162","author":"S Leibsohn","year":"1990","unstructured":"Leibsohn S, D\u2019Ablaing G, Mishell DR Jr, Schlaerth JB (1990) Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 162:968\u2013974 discus: 968\u2013974","journal-title":"Am J Obstet Gynecol"},{"key":"1027_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00404-015-3696-z","volume":"292","author":"B Bojahr","year":"2015","unstructured":"Bojahr B, Leon De Wilde R, Tchartchian G (2015) Malignancy rate of 10731 uteri morcellated during laparoscopicsupracervical hysterectomy (LASH). Arch Gynecol Obstet 292:665\u2013672","journal-title":"Arch Gynecol Obstet"},{"key":"1027_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.fertnstert.2010.05.011","volume":"95","author":"DD Baird","year":"2011","unstructured":"Baird DD, Garrett TA, Laughlin SK, Davis B, Semelka RC, Peddada SD (2011) Short-term change in growth of uterine leiomyoma: tumor growth spurts. Fertil Steril 95:242","journal-title":"Fertil Steril"},{"key":"1027_CR22","first-page":"3","volume":"100","author":"DJ DeWaay","year":"2002","unstructured":"DeWaay DJ, Syrop CH, Nygaard IE, Davis WA, Van Voorhis BJ (2002) Natural history of uterine polyps and leiomyomata. Obstet Gynecol 100:3","journal-title":"Obstet Gynecol"},{"key":"1027_CR23","doi-asserted-by":"publisher","first-page":"19887","DOI":"10.1073\/pnas.0808188105","volume":"105","author":"SD Peddada","year":"2008","unstructured":"Peddada SD, Laughlin SK, Miner K, Guyon JP, Haneke K, Vahdat HL, Semelka RC, Kowalik A, Armao D, Davis B, Baird DD (2008) Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A 105:19887","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1027_CR24","first-page":"1289","volume":"6","author":"N Kawamura","year":"1999","unstructured":"Kawamura N, Ito F, Ichimura T, Shibata S, Tsujimura A, Minakuchi K, Ishiko O, Ogita S (1999) Transient rapid growth of uterine leiomyoma in a postmenopausal woman. Oncol Rep 6:1289","journal-title":"Oncol Rep"},{"issue":"3","key":"1027_CR25","first-page":"414","volume":"83","author":"WH Parker","year":"1994","unstructured":"Parker WH, Fu YS, Berek JS (1994) Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83(3):414\u2013418","journal-title":"Obstet Gynecol"},{"key":"1027_CR26","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/aogs.12930","volume":"95","author":"M Skorstad","year":"2016","unstructured":"Skorstad M, Kent A, Lieng M (2016) Uterine leiomyosarcoma\u2014incidence, treatment, and the impact of morcellation. A nationwide cohort study. Acta Obstet Gynecol Scand 95:984\u2013990","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1027_CR27","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.2214\/ajr.181.5.1811369","volume":"181","author":"SE Rha","year":"2003","unstructured":"Rha SE, Byun JY, Jung SE, Lee SL, Cho SM, Hwang SS, Lee HG, Namkoong SE, Lee JMSO (2003) CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol 181:1369","journal-title":"AJR Am J Roentgenol"},{"key":"1027_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0015-0282(98)00193-9","volume":"70","author":"LB Schwartz","year":"1998","unstructured":"Schwartz LB, Zawin M, Carcangiu ML, Lange R, McCarthy S (1998) Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata? Fertil Steril 70:580","journal-title":"Fertil Steril"},{"key":"1027_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1046\/j.1525-1438.2002.01086.x","volume":"12","author":"A Goto","year":"2002","unstructured":"Goto A, Takeuchi S, Sugimura K, Maruo T (2002) Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 12:354","journal-title":"Int J Gynecol Cancer"},{"key":"1027_CR30","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00261-017-1076-9","volume":"42","author":"M Barral","year":"2017","unstructured":"Barral M, Place V, Dautry RI, Bendavid S, Cornelis F, Foucher R, Guerrache Y, Soyer P (2017) Magnetic resonance imaging features of uterine sarcoma and mimickers. Abdom Radiol 42:1762\u20131772","journal-title":"Abdom Radiol"},{"key":"1027_CR31","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/jmri.20207","volume":"20","author":"YO Tanaka","year":"2004","unstructured":"Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H (2004) Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging 20:998","journal-title":"J Magn Reson Imaging"},{"key":"1027_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2214\/AJR.09.4074","volume":"195","author":"K Kitajima","year":"2010","unstructured":"Kitajima K, Murakami K, Kaji Y, Sugimura K (2010) Spectrum of FDG PET\/CT findings of uterine tumors. AJR Am J Roentgenol 195:737","journal-title":"AJR Am J Roentgenol"},{"key":"1027_CR33","doi-asserted-by":"publisher","unstructured":"Rodriguez A, Zeybek B, Asoglu M, et al. (2016) Corrigendum to \u201cIncidence of occult leiomyosarcoma in presumed morcellation cases: a database study\u201d [Eur J Obstet Gynecol Reprod Biol 197(2016) 31\u201335]. 207:247. doi:10.1016\/j.ejogrb.2016.10.007","DOI":"10.1016\/j.ejogrb.2016.10.007"},{"issue":"4","key":"1027_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1634\/theoncologist.2014-0361","volume":"20","author":"A Brohl","year":"2015","unstructured":"Brohl A, Li L, Andikyan V, Obi\u010dan S, Cioffi A, Hao K, Dudle J, Ascher-Walsh C, Kasarskis A, Maki R (2015) Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma. Oncologist 20(4):433\u2013439","journal-title":"Oncologist"},{"issue":"1","key":"1027_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jamaoncol.2014.206","volume":"1","author":"J Wright","year":"2015","unstructured":"Wright J, Tergas A, Cui R, Burke W, Hou J, Ananth C, Chen L, Richards C, Neugut A, Hershman D (2015) Use of electric power morcellation and prevalence of underlying cancer in women who undergo myomectomy. JAMA Oncol 1(1):69\u201377","journal-title":"JAMA Oncol"},{"issue":"4","key":"1027_CR36","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1245\/s10434-015-4976-3","volume":"23","author":"J Yuk","year":"2015","unstructured":"Yuk J, Ji H, Shin J, Kim L, Kim S, Lee J (2015) Comparison of survival outcomes in women with unsuspected uterine malignancy diagnosed after laparotomic versus laparoscopic myomectomy: a national, population-based study. Annals Surg Oncol 23(4):1287\u20131293","journal-title":"Annals Surg Oncol"}],"container-title":["Gynecological Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10397-017-1027-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10397-017-1027-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10397-017-1027-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T06:40:17Z","timestamp":1627627217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10397-017-1027-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1027"],"URL":"https:\/\/doi.org\/10.1186\/s10397-017-1027-z","relation":{},"ISSN":["1613-2076","1613-2084"],"issn-type":[{"value":"1613-2076","type":"print"},{"value":"1613-2084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"8 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Rudi Campo: He is a consultant for Karl Storz endoscope.Prof. Rudi Leon De Wilde: He receives reimbursement of travel expenses to the International congresses by the Karl Storz Company.Prof. Hans Br\u00f6lmann: He does research projects with Olympus, Gynesonics and Gedeon-Richter without any personal fees.Prof. Peter O\u2019Donovan: He has provided consultancy advice to both Karl Storz and Lina medical in the last year in the field of ambulatory gynaecology; nothing linked with morcellation.Prof. Vasilios Tanos and Elina Symeonidou declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"25"}}